Ipamorelin is a synthetic pentapeptide and selective growth hormone secretagogue derived from GHRP analogues. It is studied for its ability to stimulate the natural release of growth hormone (GH) by activating ghrelin receptors while maintaining the body’s normal pulsatile hormone secretion.
Unlike many other GH-releasing peptides, Ipamorelin has demonstrated high selectivity in research models, stimulating GH release with minimal effect on ACTH or cortisol levels. Studies have also explored its potential role in IGF-1 production, metabolic regulation, bone density, and muscle-related growth pathways.
Each vial contains research-grade lyophilized peptide with ≥99% purity.
